We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

ADVANCED INSTRUMENTS

Advanced Instruments designs, manufactures and markets laboratory products for the clinical, food and dairy, microbio... read more Featured Products: More products

Download Mobile App




Advanced Instruments Appoints New CEO

By LabMedica International staff writers
Posted on 17 May 2017
Print article
Advanced Instruments, LLC, which designs, manufactures, and markets instrumentation and associated consumables for clinical, pharmaceutical, biotechnology, microbiology and dairy laboratories, has announced the appointment of Byron Selman as Chief Executive Officer. Mr. Selman replaces John Coughlin, who served as CEO of Advanced Instruments for over 16 years, and will continue in his retirement as a non-executive Member of the Board.

Mr. Selman brings with him a broad range of experience across multiple functional disciplines including sales, marketing, business development, engineering, operations, and general management. He joins Advanced Instruments after serving as President of Global Markets with Haemonetics Corporation, prior to which he spent over 20 years with Pall Corporation in various executive level and general management positions. Selman holds a Bachelor of Science degree in Mechanical Engineering from Case Western Reserve University, and a Master of Business Administration degree from the Frank G. Zarb School of Business at Hofstra University.

“We are excited to have Byron join Advanced Instruments,” said Craig Majernik, Managing Director at Windjammer Capital Investors, which acquired the company in October 2016. “His proven leadership abilities and demonstrated record of success position him well to lead the execution of the company’s organic and acquisition growth strategy.”

Selman said, “Advanced Instruments represents a unique opportunity, given its well-respected brand, technical know-how, and channels to market. I am encouraged by the multiple avenues available to the company to enhance and expand its well-established platform in the clinical diagnostic and biopharmaceutical tools markets.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.